SECUKINUMAB | B125504 | NOVARTIS PHARMS CORP
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Jan. 21, 2027 | Active | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12296008(formulation) · relevance 98/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 62 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.